DENVER, March 8, 2005 (PRIMEZONE) -- Medical International Technology Inc. (OTCBB:MDIR) (http://www.mitcanada.ca) a developer and manufacturer of patented needle free jet injectors for human and animal inoculation, is pleased to announce the sale of 25 of its MED-JET -- MBX low pressure needle-free injectors designed for anesthetics use to Winsor (Hong Kong) Inc.
Dr. Stephen Chow of Winsor (Hong Kong) Inc. had initially placed an order of 2 units at the 63rd Annual Meeting of the American Academy of Dermatology in New Orleans. However, after presenting the MED-JET -- MBX to Winsor's executives, the order was increased to 25 units. Winsor (Hong Kong) Inc. has also expressed their interest in becoming MIT's exclusive distributor. MIT is currently finalizing a letter of intent to grant Winsor exclusive distribution rights for its MED-JET line of injectors in Hong Kong.
Winsor (Hong Kong) Inc. is a leading esthetic products distributor in Hong Kong, with a staff of 200 employees. Winsor has the largest distribution network in Hong Kong and caters to over 500 Skin Care salons.
"We are pleased to be able to add Winsor to our list of worldwide distributors," stated Mr. Karim Menassa, President and CEO of Medical International Technology Inc. "As evidenced by the increase in the Winsor order, the reaction to our MED-JET -- MBX low pressure needle free injectors was overwhelmingly positive. As a result, we have established a number of very promising leads."
The MED-JET -- MBX has been tested for its efficacy in anesthetizing patients who receive medical treatments which involve multiple injections such as for hyperhidrosis (excessive sweating of the hands, feet and under arms) and BOTOX(r) injections.
This press release is available on the Medical International Investor Relation's site for investor questions, commentary and feedback. Investors are asked to visit http://www.agoracom.com and select the Medical International Investor Relations HUB. Alternatively, investors can e-mail their questions or comments directly to MDIR@agoracom.com or asked to be placed on the Medical International investor e-mail list to receive all future press releases directly.
About Medical International Technology, Inc. (http://www.mitcanada.ca)
MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.
The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing and technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. TelePlus Enterprises, Inc. takes no obligation to update or correct forward-looking statements.